Hello World 👋 Today we are unveiling Boltz PBC, a Public Benefit Corporation to advance AI for biology through open science, and make it accessible to every scientist building a healthier future. Follow to stay up to date, and read more on our manifesto: boltz.bio/manifesto

Nice! @boltz_bio is on a roll, and true to the company’s open source roots, remains focused on putting access to the latest Boltz models in the hands of every scientist, all across entire pharma R&D orgs (Note this is distinct from narrowly scoped discovery partnerships, or collaborations based on delivering binders against a select few targets — such partnerships have their place too!) Core belief: AI models are best used by scientists inside an org who have intimate knowledge of the ‘hurdle’ to be solved for a given drug program, have access to all prior screening campaigns, are owning all downstream experimental data, and are seeing molecules advance against multiple targets side by side to prioritize resources / effort (and yes, token spend…) across programs Congrats @GabriCorso, @boltz_bio, and @GSK teams!

very exciting stuff!

Really excited to work with the GSK team!

This team can. not. be. stopped!

Excited to announce a major partnership with GSK based around our latest frontier models!!! Two UK-based companies, one landmark AI x Bio agreement. Proud of what this says about the UK’s frontier ecosystem 🇬🇧

Incredible that an AI neolab which only came out of stealth this year (with founders relocating from MIT to London) has already struck significant deals with major pharma companies. Congrats to @boltz_bio team!

Another top 20 pharma AI partnership: @boltz_bio @GSK collaboration announced! 👇

Excited to be working with you guys and the amazing platform you have created. Time for tokenmaxxing and for new exciting science to come 📈🧬

Today, we're announcing a new partnership with @GSK! This is another step toward our mission: enabling every scientist to reshape biology and build a healthier, more sustainable future. We cannot wait to see what GSK’s scientists build with our models.

Today, we are excited to announce a major partnership with @GSK to deploy the latest Boltz models across GSK’s research organization!

Yesterday we announced the integration of Boltz with Claude Science. One thing I wanted to take a moment to highlight was the results we got from letting Claude drive the Boltz API end-to-end, so I wanted to give a bit more detail here. A thread! 🧵

RT @zachocean_: This was a really cool product to work on. Using an agent to set up and launch molecular design campaigns feels like magic…

Super excited that all the latest Boltz models are integrated into Claude Science!!! Make sure to enable the connector when you install

@AnthropicAI just dropped Claude Science - it's code sized bet that biology will be the next domain transformed by RL and agents. It's also the best place to use the new @Boltz_Bio thanks to a native integration with their recently released API. Ask Claude to design an anti-venom against a deadly toxin or find a molecule that modulates an new disease pathway and let Claude figure out the rest. What a wild time to be alive!

Introducing Claude Science, a new app designed with every stage of research in mind. Artifacts traced to their code, environments managed on demand, and 60 optional scientific databases that you can connect. Available now in beta.

Excited to share that Boltz is accessible via Claude products, including Claude Science, Anthropic’s new AI workbench for scientists!

What if you could ask a research question and run your own AI scientist? type a question → it proposes hypotheses, ranks them, and stress-tests the top ones against 5 independent models. built on @streamlit, cross-checks with @boltz_bio @OpenTargets benchmate.streamlit.app

And now, a Codex integration! I’ve found agentic workflows with Boltz to be a powerful way to distill our experience running effective screens into something users can apply directly.